Peak body CCA launches Reform Working Group and renews calls for fit-for-purpose regulatory reform of Australia’s medicinal cannabis sector
Summary
Cannabis Council Australia (CCA) is intensifying its push for structural reform of Australia's medicinal cannabis sector with the launch of its Reform Working Group. This builds on a CCA consultation currently underway on proposed revisions to product labelling requirements under TGO 93 - the first tangible output of CCA's reform agenda.
CCA's reform agenda is structured around three priority areas:
- Product Safety and Quality
- Clinical Governance
- Building the Evidence
The Reform Working Group will also be considering the practical implementation of reform, recognising that proposed changes need not only to be well designed, but practical and financially viable to implement for the sector and regulators. As reflected in CCA’s 2026–27 Budget submission, achievable regulatory reform is ultimately the means to a sustainable sector capable of delivering equitable patient access to medicinal cannabis across Australia. CCA indicated it will be hosting events in Canberra in June to further advance the sector’s reform agenda, with more details to follow.
